Resmed Inc
RMD- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000943819
In the last 90 days, Resmed Inc insiders filed 0 open-market purchases and 5 sales; 891 institutions reported holding it in 13F filings for Q2 2026, worth $19.4B in total; Giverny Capital is the only superinvestor holding it.
Other share classesRSMDF
Superinvestors holding RMD, Q2 2026
1 superinvestor reports holding Resmed Inc on Form 13F, worth $75.5M in total. Weight is Resmed Inc's share of each 13F portfolio; actions compare shares with Q1 2026.
| Superinvestor | % of portfolio | Shares | Value | vs. previous quarter |
|---|---|---|---|---|
| Giverny CapitalFrançois Rochon | 2.6% | 387,665 | $75.5M | Added+68.5% |
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of RMD each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q2 2026
1 superinvestor holding at quarter end
- Added
- Giverny Capital (+68.5%)
Q1 2026
1 superinvestor holding at quarter end
- Reduced
- Giverny Capital (−2.3%)
Q4 2025
1 superinvestor holding at quarter end
- Reduced
- Giverny Capital (0.0%)
Q3 2025
1 superinvestor holding at quarter end
Q4 2024
0 superinvestors holding at quarter end
- Sold out
- Coatue Management
Q3 2024
1 superinvestor holding at quarter end
Q2 2024
0 superinvestors holding at quarter end
- Sold out
- Maverick Capital
Q1 2024
1 superinvestor holding at quarter end
Q4 2023
0 superinvestors holding at quarter end
- Sold out
- Maverick Capital
Q3 2023
1 superinvestor holding at quarter end
- Added
- Maverick Capital (+59.0%)
Q2 2023
1 superinvestor holding at quarter end
- Added
- Maverick Capital (+159.3%)
Q1 2023
1 superinvestor holding at quarter end
- New
- Maverick Capital
- Sold out
- Giverny Capital